惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园 - 叶小钗
D
Docker
Google DeepMind News
Google DeepMind News
Y
Y Combinator Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Blog — PlanetScale
Blog — PlanetScale
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
U
Unit 42
博客园 - 【当耐特】
N
Netflix TechBlog - Medium
V
Visual Studio Blog
Microsoft Azure Blog
Microsoft Azure Blog
博客园_首页
Recent Announcements
Recent Announcements
GbyAI
GbyAI
T
Tailwind CSS Blog
S
SegmentFault 最新的问题
WordPress大学
WordPress大学
T
The Blog of Author Tim Ferriss
Engineering at Meta
Engineering at Meta
L
LangChain Blog
A
About on SuperTechFans
M
MIT News - Artificial intelligence
B
Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript
SA Transcripts · 2026-05-06 · via All Articles on Seeking Alpha

Q1: 2026-05-05 Earnings Summary

EPS of -$0.15 beats by $0.03

 | 

Revenue of

$34.45M

(7.75% Y/Y)

beats by $271.00K

Neuronetics, Inc. (STIM) Q1 2026 Earnings Call May 5, 2026 8:30 AM EDT

Company Participants

Daniel Reuvers - CEO, President & Director

Conference Call Participants

Mark Klausner - Westwicke Partners, LLC
William Plovanic - Canaccord Genuity Corp., Research Division
Adam Maeder - Piper Sandler & Co., Research Division
Daniel Stauder - Citizens JMP Securities, LLC, Research Division

Presentation

Operator

Good day and thank you for standing by. Welcome to the Neuronetics First Quarter 2026 Financial and Operating Results Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today.

Mark Klausner
Westwicke Partners, LLC

Good morning, and thank you for joining us for the Neuronetics First Quarter 2026 Conference Call. Joining me on today's call is Neuronetics' President and Chief Executive Officer, Dan Reuvers. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance and other operational issues and metrics.

Actual results can differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. For a discussion of risks and uncertainties associated with Neuronetics' business, I encourage you to review the company's filings with the Securities and Exchange Commission, including the company's annual report on Form 10-K, which was filed in March and the company's quarterly report on Form 10-Q for the quarter ended March 31, 2026. The company disclaims any obligation to update any forward-looking statements made during the course of this call, except as required by law.

During the call, we'll also discuss certain information on